DK126322B - Analogifremgangsmåde til fremstilling af 17-oxygenerede 2α,3α-epithio-18-methyl-5α-androstanderivater. - Google Patents
Analogifremgangsmåde til fremstilling af 17-oxygenerede 2α,3α-epithio-18-methyl-5α-androstanderivater.Info
- Publication number
- DK126322B DK126322B DK145869AA DK145869A DK126322B DK 126322 B DK126322 B DK 126322B DK 145869A A DK145869A A DK 145869AA DK 145869 A DK145869 A DK 145869A DK 126322 B DK126322 B DK 126322B
- Authority
- DK
- Denmark
- Prior art keywords
- epithio
- oxygenated
- methyl
- preparation
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
- C07D331/02—Three-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1770268 | 1968-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK126322B true DK126322B (da) | 1973-07-02 |
Family
ID=11951100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK145869AA DK126322B (da) | 1968-03-18 | 1969-03-18 | Analogifremgangsmåde til fremstilling af 17-oxygenerede 2α,3α-epithio-18-methyl-5α-androstanderivater. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3660382A (de) |
| CH (1) | CH555328A (de) |
| DE (1) | DE1913724A1 (de) |
| DK (1) | DK126322B (de) |
| FR (1) | FR2004188A1 (de) |
| GB (1) | GB1263804A (de) |
| NL (1) | NL6904169A (de) |
-
1969
- 1969-03-17 US US807916A patent/US3660382A/en not_active Expired - Lifetime
- 1969-03-18 GB GB04307/69A patent/GB1263804A/en not_active Expired
- 1969-03-18 DK DK145869AA patent/DK126322B/da unknown
- 1969-03-18 CH CH407169A patent/CH555328A/de not_active IP Right Cessation
- 1969-03-18 DE DE19691913724 patent/DE1913724A1/de active Pending
- 1969-03-18 NL NL6904169A patent/NL6904169A/xx unknown
- 1969-03-18 FR FR6907745A patent/FR2004188A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US3660382A (en) | 1972-05-02 |
| DE1913724A1 (de) | 1969-10-09 |
| CH555328A (de) | 1974-10-31 |
| FR2004188A1 (de) | 1969-11-21 |
| GB1263804A (en) | 1972-02-16 |
| NL6904169A (de) | 1969-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK126193B (da) | Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin. | |
| DK122964B (da) | Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater. | |
| DK131628B (da) | Fremgangsmåde til fremstilling af tioninderivater. | |
| DK129656B (da) | Analogifremgangsmåde til fremstilling af derivater af S-triazin. | |
| DK126994B (da) | Analogifremgangsmåde til fremstilling af aminopyridinderivater. | |
| DK125091B (da) | Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner. | |
| DK125852B (da) | Fremgangsmåde til fremstilling af erythromycylamin. | |
| DK133430B (da) | Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner. | |
| DK122124B (da) | Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider. | |
| DK123236B (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner. | |
| DK123232B (da) | Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler. | |
| DK121956B (da) | Analogifremgangsmåde til fremstilling af 1,2,4-oxadiazolderivater. | |
| DK127971B (da) | Analogifremgangsmåde til fremstilling af halogenmethyl-1,3-polyhalogen-2-propylethere. | |
| DK123300B (da) | Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler. | |
| DK125464C (da) | Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater. | |
| DK121052B (da) | Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater. | |
| DK120292B (da) | Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater. | |
| DK128008B (da) | Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner. | |
| DK123353B (da) | Analogifremgangsmåde til fremstilling af 6,7-methylen-20-spirox-4-en-3-on-forbindelser. | |
| DK121436B (da) | Analogifremgangsmåde til fremstilling af 14α,17α-methylendioxypregnanderivater. | |
| DK128680B (da) | Analogifremgangsmåde til fremstilling af phenazinderivater. | |
| DK118291B (da) | Analogifremgangsmåde til fremstilling af 10α-alkoxy-9,10-dihydroergolinderivater. | |
| DK123818B (da) | Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider. | |
| DK127554B (da) | Analogifremgangsmåde til fremstilling af 14α 17α-methylendioxy-19-nor-progesteronderivater. | |
| DK122816B (da) | Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner. |